BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:APL-9796 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of APL-9796\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06846554-540@assetmemo.bio
DTSTAMP:20261121T004031Z
DTSTART;VALUE=DATE:20270830
DTEND;VALUE=DATE:20270831
SUMMARY:APL-9796: Phase 2 readout est. (NCT06846554)
DESCRIPTION:APL-9796\, phase 2\, Pulmonary Arterial Hypertension.\nStudy: A
  Trial of "APL-9796'' in Adults With Pulmonary Hypertension\nEstimated pri
 mary completion: 30 August 2027. This is a ClinicalTrials.gov estimate\, n
 ot a confirmed readout date\, and it can move.\nDrug page: https://assetme
 mo.bio/drug/apl-9796#upcoming-events\nRegistry record: https://clinicaltri
 als.gov/study/NCT06846554
URL:https://assetmemo.bio/drug/apl-9796#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
